One week it was Pfizer buying GlaxoSmithKline. Then it was Johnson & Johnson or Roche swallowing GSK.It was a busy spring.And wasn’t GSK giving up research on new drugs anyway?
Wrong on the research and ignore the “hullabaloo” about a takeover, Moncef Slaoui, GSK’s chief of vaccines, said in a recent interview.
Hey, check out all the research scientist jobs. Post your resume today!
